Information about Loosen Pharmabio
My details
*
*
*

Loosen Pharmabio (SRL)

BE 0563.958.196

Rue Anne-Croix 6, 1430 Rebecq

Company information

Status
Active

Enterprise number

BE0563.958.196

VAT liability
No
Established
14-10-2014
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Medical laboratory and imaging activities
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Loosen Pharmabio

2024 2023 2022 2021
Profit/Loss € 148,350 16 % € 127,346 0 % € 127,069 4 % € 122,492
Equity € 23,802 16 % € 20,452 -53 % € 43,106 -35 % € 66,037
Gross margin € 211,649 9 % € 194,931 4 % € 187,097 2 % € 184,249

Publications from Loosen Pharmabio

Date Publication
16-01-2023 Modification Legal Form - Denomination - Resignations, Appointments (FR)
08-05-2017 Registered Office (FR)
27-04-2015 Miscellaneous (FR)
23-10-2014 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the enterprise number of Loosen Pharmabio?
The enterprise number of Loosen Pharmabio is BE 0563.958.196.
Wat is the PEPPOL ID of Loosen Pharmabio?
The PEPPOL ID of Loosen Pharmabio is 0208:0563958196. Log in or start a free trial to see the full overview.
When was Loosen Pharmabio founded?
Loosen Pharmabio was founded on 14-10-2014.
What is the address of Loosen Pharmabio?
The current registered office of Loosen Pharmabio is located at Rue Anne-Croix 6, 1430 Rebecq.
When was the last time Loosen Pharmabio filed their annual financial statements?
The most recent financial statements of Loosen Pharmabio were filed on 07-07-2025.
How many employees does Loosen Pharmabio have?
There are currently no employees working at Loosen Pharmabio or no workforce information is available.
What is the annual turnover of Loosen Pharmabio?
At the time of its most recent financial statements, Loosen Pharmabio did not publish any turnover figures. Loosen Pharmabio reported a gross margin of €211,649.08.

Sources